Effects of a selective PPARα modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model.
Biochem Biophys Res Commun
; 625: 116-121, 2022 10 15.
Article
in En
| MEDLINE
| ID: mdl-35952608
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oryzias
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Non-alcoholic Fatty Liver Disease
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2022
Document type:
Article
Affiliation country:
Japón